HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Eri Toda Kato Selected Research

Acute Coronary Syndrome

10/2015The effect of rivaroxaban on myocardial infarction in the ATLAS ACS 2 - TIMI 51 trial.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Eri Toda Kato Research Topics

Disease

2Stroke (Strokes)
01/2022 - 10/2015
2Myocardial Infarction
01/2022 - 10/2015
1Embolism (Embolus)
01/2022
1Hemorrhage
01/2022
1Atrial Fibrillation
01/2022
1Obesity
06/2021
1Heart Failure
06/2021
1Acute Coronary Syndrome
10/2015
1ST Elevation Myocardial Infarction
10/2015

Drug/Important Bio-Agent (IBA)

2RivaroxabanIBA
01/2022 - 10/2015
1apixabanIBA
01/2022
1AnticoagulantsIBA
01/2022
1CreatinineIBA
01/2022
1Vitamin KFDA Link
01/2022
1Warfarin (Coumadin)FDA LinkGeneric
01/2022
1Factor Xa (Coagulation Factor Xa)IBA
01/2022
1LipidsIBA
06/2021
1TroponinIBA
10/2015
1MB Form Creatine KinaseIBA
10/2015

Therapy/Procedure

3Therapeutics
01/2022 - 10/2015